Neximmune Stock Forecast - Polynomial Regression

NEXI Stock  USD 3.30  0.15  4.76%   
The Polynomial Regression forecasted value of Neximmune on the next trading day is expected to be 4.31 with a mean absolute deviation of  1.14  and the sum of the absolute errors of 69.56. Neximmune Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Neximmune stock prices and determine the direction of Neximmune's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neximmune's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Neximmune's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Neximmune's systematic risk associated with finding meaningful patterns of Neximmune fundamentals over time.
Check out Historical Fundamental Analysis of Neximmune to cross-verify your projections.
For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
  
The Neximmune's current Inventory Turnover is estimated to increase to -83.92. The current Payables Turnover is estimated to decrease to 0.41. The Neximmune's current Common Stock Shares Outstanding is estimated to increase to about 1.1 B, while Net Loss is projected to decrease to (59.1 M).
Most investors in Neximmune cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Neximmune's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Neximmune's price structures and extracts relationships that further increase the generated results' accuracy.
Neximmune polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Neximmune as well as the accuracy indicators are determined from the period prices.

Neximmune Polynomial Regression Price Forecast For the 19th of April

Given 90 days horizon, the Polynomial Regression forecasted value of Neximmune on the next trading day is expected to be 4.31 with a mean absolute deviation of 1.14, mean absolute percentage error of 3.18, and the sum of the absolute errors of 69.56.
Please note that although there have been many attempts to predict Neximmune Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neximmune's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Neximmune Stock Forecast Pattern

Backtest NeximmuneNeximmune Price PredictionBuy or Sell Advice 

Neximmune Forecasted Value

In the context of forecasting Neximmune's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Neximmune's downside and upside margins for the forecasting period are 0.03 and 18.36, respectively. We have considered Neximmune's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.30
4.31
Expected Value
18.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Neximmune stock data series using in forecasting. Note that when a statistical model is used to represent Neximmune stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria119.2662
BiasArithmetic mean of the errors None
MADMean absolute deviation1.1403
MAPEMean absolute percentage error0.1646
SAESum of the absolute errors69.5559
A single variable polynomial regression model attempts to put a curve through the Neximmune historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Neximmune

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neximmune. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neximmune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.152.9516.98
Details
Intrinsic
Valuation
LowRealHigh
0.132.5116.54
Details
1 Analysts
Consensus
LowTargetHigh
1.822.002.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.00-0.060.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neximmune. Your research has to be compared to or analyzed against Neximmune's peers to derive any actionable benefits. When done correctly, Neximmune's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Neximmune.

Other Forecasting Options for Neximmune

For every potential investor in Neximmune, whether a beginner or expert, Neximmune's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neximmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neximmune. Basic forecasting techniques help filter out the noise by identifying Neximmune's price trends.

Neximmune Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neximmune stock to make a market-neutral strategy. Peer analysis of Neximmune could also be used in its relative valuation, which is a method of valuing Neximmune by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Neximmune Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neximmune's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neximmune's current price.

Neximmune Market Strength Events

Market strength indicators help investors to evaluate how Neximmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neximmune shares will generate the highest return on investment. By undertsting and applying Neximmune stock market strength indicators, traders can identify Neximmune entry and exit signals to maximize returns.

Neximmune Risk Indicators

The analysis of Neximmune's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neximmune's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neximmune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Neximmune offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neximmune's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neximmune Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neximmune Stock:
Check out Historical Fundamental Analysis of Neximmune to cross-verify your projections.
For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Neximmune Stock analysis

When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(42.05)
Return On Assets
(0.78)
Return On Equity
(1.57)
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.